Tronox Reports First Quarter 2026 Financial Results
STAMFORD, Conn.,
First Quarter 2026 Financial Highlights:
- Revenue of
$760 million , a 4% increase compared to the prior quarter and a 3% increase compared to the prior year - Loss from operations of
$41 million ; Net loss attributable toTronox of$103 million including$15 million of restructuring and other charges, net of taxes, primarily associated with the closure of the Company's Botlek andFuzhou pigment plants; Adjusted net loss attributable toTronox was$88 million (non-GAAP) - GAAP diluted loss per share was
$0.65 ; Adjusted diluted loss per share was$0.55 (non-GAAP) - Adjusted EBITDA of
$62 million ; Adjusted EBITDA margin of 8.2% (non-GAAP) - Capital expenditures of
$67 million in the quarter
Updated Outlook:
- Expect free cash flow to be positive in Q2 2026, largely offsetting Q1 cash use; Expect to deliver meaningful positive free cash flow for full year 2026
- Expect Q2 2026 TiO2 volumes to increase sequentially in the high single-digit percentage range
- Expect Q2 2026 zircon volume levels to moderate slightly compared to Q1
- TiO2 and zircon Q2 2026 volumes could be higher, depending on regional inventory availability
- TiO2 and zircon pricing both expected to improve sequentially in the mid-single-digit percentage range in Q2 2026 as a result of announced price increases and cost input-related surcharges
- Q2 2026 Adjusted EBITDA expected to be
$65-$85 million
This outlook is based on
|
|
|
------ |
|
Note: For the Company's guidance with respect to second quarter 2026 Adjusted EBITDA and free cash flow, we are not able to provide without unreasonable effort the most directly comparable GAAP financial measure, or reconciliation to such GAAP financial measure, because certain items that impact such measures are uncertain, out of the Company's control or cannot be reasonably predicted. |
|
|
Summary of Select Financial Results for the Quarter Ending
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($M unless otherwise noted) |
|
Q1 2026 |
Q1 2025 |
Y-o-Y % ∆ |
Q4 2025 |
Q-o-Q % ∆ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
|
3 % |
|
4 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TiO 2 |
|
|
|
5 % |
|
7 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zircon |
|
|
|
29 % |
|
14 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other products |
|
|
(35) % |
|
(27) % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) from operations |
|
( |
( |
n/m |
( |
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) attributable to |
( |
( |
n/m |
( |
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP diluted (loss) per share |
( |
( |
n/m |
( |
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted diluted (loss) per share |
( |
( |
n/m |
( |
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
|
(45) % |
|
9 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA Margin % |
|
8.2 % |
15.2 % |
(700) bps |
7.8 % |
40 bps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Free cash flow |
|
( |
( |
n/m |
|
n/m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Y-o-Y % ∆ |
Q-o-Q % ∆ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Volume |
Price / Mix |
FX |
Volume |
Price / Mix |
FX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TiO2 |
5 % |
(4) % |
4 % |
4 % |
3 % |
0 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zircon |
57 % |
(28) % |
— % |
14 % |
0 % |
— % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CEO's Remarks
Chief Executive Officer
"From a cost perspective, we saw sequential benefits from actions underway, including our cost improvement program, which remains on track to deliver
First Quarter 2026 Results
(Comparisons are to prior year (Q1 2026 vs. Q1 2025) unless otherwise noted)
The Company recorded first quarter revenue of
Revenue from TiO2 sales was
Zircon revenue increased 29% to
Revenue from other products was
Net loss attributable to
Adjusted EBITDA of
Sequentially, Adjusted EBITDA increased 9% due to higher average TiO2 selling prices including mix, higher sales volumes of TiO2 and zircon, and lower production costs, partially offset by unfavorable exchange rate impacts, higher freight costs, and higher corporate costs.
The Company's selling, general and administrative expenses were
Balance Sheet, Cash Flow and Capital Allocation
Free cash flow for the quarter was a use of
Rare Earths
Outlook
Webcast Conference Call
Replay: A webcast replay will be available at investor.tronox.com following the call.
About
Cautionary Statement about Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, synergies or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.
Use of Non-GAAP Information
To provide investors and others with additional information regarding the financial results of
Investor Relations and Media Contact: Jennifer Guenther
+1.203.705.3701 extension: 103701 (Media)
+1.646.960.6598 (Investor Relations)
|
|
|||
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS ( |
|||
|
(UNAUDITED) |
|||
|
(Millions of |
|||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
2026 |
|
2025 |
|
Net sales |
$ 760 |
|
$ 738 |
|
Cost of goods sold |
716 |
|
639 |
|
Gross profit |
44 |
|
99 |
|
Restructuring and other charges |
14 |
|
86 |
|
Selling, general and administrative expenses |
71 |
|
74 |
|
Loss from operations |
(41) |
|
(61) |
|
Interest expense |
(53) |
|
(42) |
|
Interest income |
2 |
|
2 |
|
Loss on extinguishment of debt |
— |
|
— |
|
Other expense, net |
(12) |
|
(5) |
|
Loss before income taxes |
(104) |
|
(106) |
|
Income tax provision |
— |
|
(5) |
|
Net loss |
(104) |
|
(111) |
|
Net loss attributable to noncontrolling interest |
(1) |
|
— |
|
Net loss attributable to |
$ (103) |
|
$ (111) |
|
|
|
|
|
|
|
|
|
|
|
Loss per share: |
|
|
|
|
Basic |
$ (0.65) |
|
$ (0.70) |
|
Diluted |
$ (0.65) |
|
$ (0.70) |
|
|
|
|
|
|
Weighted average shares outstanding, basic (in thousands) |
158,889 |
|
158,138 |
|
Weighted average shares outstanding, diluted (in thousands) |
158,889 |
|
158,138 |
|
|
|
|
|
|
Other Operating Data: |
|
|
|
|
Capital expenditures |
67 |
|
110 |
|
Depreciation, depletion and amortization expense |
75 |
|
71 |
|
|
|||
|
RECONCILIATION OF NON- |
|||
|
(UNAUDITED) |
|||
|
(Millions of |
|||
|
|
|
|
|
|
RECONCILIATION OF NET LOSS ATTRIBUTABLE TO TRONOX HOLDINGS PLC ( |
|||
|
TO ADJUSTED NET LOSS ATTRIBUTABLE TO TRONOX HOLDINGS PLC (NON- |
|||
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
2026 |
|
2025 |
|
|
|
|
|
|
Net loss attributable to |
$ (103) |
|
$ (111) |
|
|
|
|
|
|
Restructuring and other charges (a) |
14 |
|
86 |
|
Other (b) |
1 |
|
1 |
|
Adjusted net loss attributable to |
$ (88) |
|
$ (24) |
|
|
|
|
|
|
Diluted net loss per share ( |
$ (0.65) |
|
$ (0.70) |
|
|
|
|
|
|
Restructuring and other charges, per share |
0.09 |
|
0.54 |
|
Other, per share |
0.01 |
|
0.01 |
|
Diluted adjusted net loss per share attributable to |
$ (0.55) |
|
$ (0.15) |
|
|
|
|
|
|
Weighted average shares outstanding, diluted (in thousands) |
158,889 |
|
158,138 |
|
|
|
|
|
|
(1) Diluted adjusted net loss per share attributable to |
|||
|
(a) Represents restructuring and other charges associated with the Botlek and |
|||
|
(b) Represents other activity not representative of the ongoing operations of the Company. |
|||
|
|
|||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
|
(UNAUDITED) |
|||
|
(Millions of |
|||
|
|
|
|
|
|
ASSETS |
|
|
|
|
Current Assets |
|
|
|
|
Cash and cash equivalents |
$ 126 |
|
$ 199 |
|
Restricted cash |
12 |
|
12 |
|
Accounts receivable (net of allowance for credit losses of |
331 |
|
289 |
|
Inventories, net |
1,577 |
|
1,652 |
|
Prepaid and other assets |
119 |
|
112 |
|
Income taxes receivable |
1 |
|
1 |
|
Total current assets |
2,166 |
|
2,265 |
|
|
|
|
|
|
Noncurrent Assets |
|
|
|
|
Property, plant and equipment, net |
1,973 |
|
2,007 |
|
Mineral leaseholds, net |
594 |
|
608 |
|
Intangible assets, net |
208 |
|
214 |
|
Lease right of use assets, net |
169 |
|
173 |
|
Deferred tax assets |
834 |
|
833 |
|
Other long-term assets |
113 |
|
117 |
|
Total assets |
$ 6,057 |
|
$ 6,217 |
|
|
|
|
|
|
LIABILITIES AND EQUITY |
|
|
|
|
Current Liabilities |
|
|
|
|
Accounts payable |
$ 419 |
|
$ 481 |
|
Accrued liabilities |
231 |
|
274 |
|
Short-term lease liabilities |
22 |
|
22 |
|
Obligations under inventory financing arrangement |
50 |
|
50 |
|
Short-term debt |
133 |
|
51 |
|
Long-term debt due within one year |
39 |
|
39 |
|
Income taxes payable |
1 |
|
2 |
|
Total current liabilities |
895 |
|
919 |
|
|
|
|
|
|
Noncurrent Liabilities |
|
|
|
|
Long-term debt, net |
3,124 |
|
3,132 |
|
Pension and postretirement healthcare benefits |
80 |
|
81 |
|
Asset retirement obligations |
207 |
|
198 |
|
Environmental liabilities |
39 |
|
39 |
|
Long-term lease liabilities |
146 |
|
148 |
|
Deferred tax liabilities |
204 |
|
208 |
|
Other long-term liabilities |
41 |
|
43 |
|
Total liabilities |
4,736 |
|
4,768 |
|
|
|
|
|
|
Commitments and Contingencies |
|
|
|
|
Shareholders' Equity |
|
|
|
|
|
2 |
|
2 |
|
Capital in excess of par value |
2,101 |
|
2,103 |
|
(Accumulated deficit) retained earnings |
(73) |
|
30 |
|
Accumulated other comprehensive loss |
(741) |
|
(717) |
|
|
1,289 |
|
1,418 |
|
Noncontrolling interest |
32 |
|
31 |
|
Total equity |
1,321 |
|
1,449 |
|
Total liabilities and equity |
$ 6,057 |
|
$ 6,217 |
|
|
|||
|
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||
|
(UNAUDITED) |
|||
|
(Millions of |
|||
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
2026 |
|
2025 |
|
Cash Flows from Operating Activities: |
|
|
|
|
Net loss |
$ (104) |
|
$ (111) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
Depreciation, depletion and amortization |
75 |
|
71 |
|
Deferred income taxes |
- |
|
4 |
|
Share-based compensation expense |
6 |
|
5 |
|
Amortization of deferred debt issuance costs and discount on debt |
3 |
|
2 |
|
Restructuring and other charges |
14 |
|
86 |
|
Other non-cash items affecting net loss |
16 |
|
12 |
|
Changes in assets and liabilities: |
|
|
|
|
Increase in accounts receivable, net of allowance for credit losses |
(43) |
|
(49) |
|
Decrease (increase) in inventories, net |
67 |
|
(35) |
|
Decrease in prepaid and other assets |
5 |
|
18 |
|
Restructuring payments |
(19) |
|
(2) |
|
Decrease in accounts payable and accrued liabilities |
(80) |
|
(22) |
|
Net changes in income tax payables and receivables |
- |
|
(4) |
|
Changes in other non-current assets and liabilities |
(8) |
|
(7) |
|
Cash used in operating activities |
(68) |
|
(32) |
|
|
|
|
|
|
Cash Flows from Investing Activities: |
|
|
|
|
Capital expenditures |
(67) |
|
(110) |
|
Loans |
- |
|
15 |
|
Cash used in investing activities |
(67) |
|
(95) |
|
|
|
|
|
|
Cash Flows from Financing Activities: |
|
|
|
|
Repayments of short-term debt |
(97) |
|
(6) |
|
Repayments of long-term debt |
(8) |
|
(6) |
|
Repayments of inventory financing arrangement |
(50) |
|
- |
|
Proceeds from short-term debt |
182 |
|
121 |
|
Proceeds from inventory financing arrangement |
50 |
|
- |
|
Debt issuance costs |
(2) |
|
- |
|
Dividends paid |
(8) |
|
- |
|
Restricted stock and performance-based shares settled in cash for withholding taxes |
- |
|
(1) |
|
Cash provided by financing activities |
67 |
|
108 |
|
|
|
|
|
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash |
(5) |
|
5 |
|
|
|
|
|
|
Net decrease in cash and cash equivalents and restricted cash |
(73) |
|
(14) |
|
Cash and cash equivalents and restricted cash at beginning of period |
211 |
|
152 |
|
Cash and cash equivalents and restricted cash at end of period |
$ 138 |
|
$ 138 |
|
|
|||
|
RECONCILIATION OF NET LOSS TO EBITDA AND ADJUSTED EBITDA, ADJUSTED EBITDA AS A % OF NET SALES AND NET DEBT TO TRAILING-TWELVE MONTHS ADJUSTED EBITDA (NON- |
|||
|
(UNAUDITED) |
|||
|
(Millions of |
|||
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
2026 |
|
2025 |
|
|
|
|
|
|
Net loss ( |
$ (104) |
|
$ (111) |
|
Interest expense |
53 |
|
42 |
|
Interest income |
(2) |
|
(2) |
|
Income tax provision |
— |
|
5 |
|
Depreciation, depletion and amortization expense |
75 |
|
71 |
|
EBITDA (non- |
22 |
|
5 |
|
Share-based compensation (a) |
6 |
|
5 |
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (b) |
4 |
|
7 |
|
Accounts receivable securitization program (c) |
3 |
|
4 |
|
Foreign currency remeasurement (d) |
7 |
|
1 |
|
Restructuring and other charges (e) |
14 |
|
86 |
|
Other items (f) |
6 |
|
4 |
|
Adjusted EBITDA (non- |
$ 62 |
|
$ 112 |
|
|
|
|
|
|
|
Three Months Ended |
||
|
|
2026 |
|
2025 |
|
Net sales |
$ 760 |
|
$ 738 |
|
Net loss ( |
$ (104) |
|
$ (111) |
|
Net loss ( |
(13.7) % |
|
(15.0) % |
|
Adjusted EBITDA (non- |
8.2 % |
|
15.2 % |
|
|
|
|
|
|
|
|
|
|
|
Long-term debt, net |
$ 3,124 |
|
$ 3,132 |
|
Short-term debt |
133 |
|
51 |
|
Long-term debt due within one year |
39 |
|
39 |
|
(Less) Cash and cash equivalents |
(126) |
|
(199) |
|
Net debt |
$ 3,170 |
|
$ 3,023 |
|
Trailing-twelve month Adjusted EBITDA (non- |
$ 286 |
|
$ 336 |
|
Net debt to trailing-twelve month Adjusted EBITDA (non- |
11.1x |
|
9.0x |
|
|
|
|
|
|
|
|
|
|
|
(a) Represents non-cash share-based compensation. |
|||
|
(b) Primarily represents accretion expense and other noncash adjustments to asset retirement obligations and environmental liabilities. |
|||
|
(c) Primarily represents expenses associated with the Company's accounts receivable securitization program which is used as a source of liquidity in the Company's overall capital structure. |
|||
|
(d) Represents realized and unrealized gains and losses associated with foreign currency remeasurement related to third-party and intercompany receivables and liabilities denominated in a currency other than the functional currency of the entity holding them, which are included in "Other expense, net" in the unaudited Condensed Consolidated Statements of Operations. |
|||
|
(e) Represents restructuring and other charges associated with the Botlek and |
|||
|
(f) Includes noncash pension and postretirement costs, asset write-offs and other items included in "Selling general and administrative expenses", "Cost of goods sold" and "Other expense, net" in the unaudited Condensed Consolidated Statements of Operations. |
|||
|
|
|
|
FREE CASH FLOW (NON- |
|
|
(UNAUDITED) |
|
|
(Millions of |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table reconciles cash used in operating activities to free cash flow for |
|
|
|
|
|
|
Three Months Ended
|
|
Cash used in operating activities |
$ (68) |
|
Capital expenditures |
(67) |
|
Free cash flow (non- |
$ (135) |
|
|
|||||||
|
RECONCILIATION OF TRAILING TWELVE MONTH NET LOSS TO EBITDA AND ADJUSTED EBITDA (NON- |
|||||||
|
(UNAUDITED) |
|||||||
|
(Millions of |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Trailing Twelve Month |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss ( |
|
$ (85) |
$ (100) |
$ (177) |
$ (104) |
|
$ (466) |
|
Interest expense |
|
45 |
48 |
54 |
53 |
|
200 |
|
Interest income |
|
(1) |
(1) |
(2) |
(2) |
|
(6) |
|
Income tax provision |
|
4 |
8 |
(2) |
— |
|
10 |
|
Depreciation, depletion and amortization expense |
|
74 |
75 |
82 |
75 |
|
306 |
|
EBITDA (non- |
|
37 |
30 |
(45) |
22 |
|
44 |
|
Share-based compensation (a) |
|
4 |
5 |
6 |
6 |
|
21 |
|
Foreign currency remeasurement (b) |
|
(2) |
— |
7 |
7 |
|
12 |
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c) |
|
7 |
6 |
(11) |
4 |
|
6 |
|
Accounts receivable securitization program (d) |
|
3 |
3 |
3 |
3 |
|
12 |
|
Restructuring and other charges (e) |
|
42 |
25 |
79 |
14 |
|
160 |
|
Other items (f) |
|
2 |
5 |
18 |
6 |
|
31 |
|
Adjusted EBITDA (non- |
|
$ 93 |
$ 74 |
$ 57 |
$ 62 |
|
$ 286 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Represents non-cash share-based compensation. |
|||||||
|
(b) Represents realized and unrealized gains and losses associated with foreign currency remeasurement related to third-party and intercompany receivables and liabilities denominated in a currency other than the functional currency of the entity holding them, which are included in "Other expense, net" in the unaudited Condensed Consolidated Statements of Operations. |
|||||||
|
(c) Primarily represents accretion expense and other noncash adjustments to asset retirement obligations and environmental liabilities. |
|||||||
|
(d) Primarily represents expenses associated with the Company's accounts receivable securitization program which is used as a source of liquidity in the Company's overall capital structure. |
|||||||
|
(e) Represents restructuring and other charges associated with the Botlek and |
|||||||
|
(f) Includes noncash pension and postretirement costs, asset write-offs, severance expense and other items included in "Selling general and administrative expenses", "Cost of goods sold" and "Other expense, net" in the unaudited Condensed Consolidated Statements of Operations. |
|||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/tronox-reports-first-quarter-2026-financial-results-302764663.html
SOURCE